Retour sur lavenir.net
   NYXOAH 1.382 € (+1,77 %)     ARGENX SE 866.800 € (+1,52 %)     GBL 75.050 € (+0,07 %)     SIPEF 105.800 € (+0,57 %)     UCB 210.000 € (+2,14 %)     VIOHALCO 15.980 € (-2,56 %)     ONTEX GROUP 2.175 € (-0,46 %)     PROXIMUS 6.310 € (+2,02 %)     D'IETEREN GROUP 168.500 € (-1,06 %)     WDP 21.000 € (+0,10 %)     KBC 130.600 € (-1,02 %)     XIOR 25.450 € (+0,59 %)     ELIA GROUP 114.600 € (-2,05 %)     CIE BOIS SAUVAGE 300.000 € (-0,33 %)     BIOTALYS 1.950 € (-8,88 %)     AGEAS 75.100 € (0,00 %)     SYENSQO 80.050 € (-0,44 %)     LOTUS BAKERIES 12 100.000 € (+1,68 %)     UMICORE 21.440 € (-4,37 %)     AB INBEV 69.160 € (+2,95 %)     GIMV 45.400 € (-0,22 %)     BEKAERT 37.050 € (-0,80 %)     ACKERMANS V.HAAREN 268.400 € (-1,32 %)     DEME GROUP 178.000 € (-1,98 %)     MELEXIS 64.050 € (-3,61 %)     AZELIS GROUP 11.960 € (-1,24 %)     TUBIZE-FIN 178.700 € (+1,77 %)     SOFINA 255.200 € (+0,08 %)     RECTICEL 12.580 € (-2,48 %)     VGP 71.000 € (-0,56 %)     FAGRON 21.050 € (+0,24 %)     MONTEA 63.400 € (-0,16 %)     CARE PROPERTY INV. 12.300 € (+0,99 %)     SHURGARD 22.500 € (-0,44 %)     BARCO 7.405 € (-0,87 %)     ASCENCIO 52.300 € (-0,19 %)     FLUXYS BELGIUM D 21.800 € (-2,68 %)     VASTNED 27.950 € (-1,06 %)     CMB.TECH 16.720 € (+0,12 %)     JENSEN-GROUP 74.600 € (0,00 %)     CENERGY 22.380 € (-4,20 %)     ONWARD MEDICAL 2.695 € (-1,64 %)     BREDERODE 105.400 € (-0,38 %)     AEDIFICA 65.650 € (-0,08 %)     SOLVAY 25.960 € (+0,31 %)     EVS 27.800 € (-1,59 %)     KINEPOLIS GROUP 48.300 € (-0,10 %)     KBC ANCORA 93.000 € (-1,27 %)     BPOST 1.212 € (-0,66 %)     COLRUYT 38.560 € (+1,31 %)     TINC 11.040 € (+0,18 %)     VAN DE VELDE 30.000 € (+0,33 %)     IBA 15.460 € (+2,38 %)     AGFA-GEVAERT 0.393 € (-2,36 %)     CFE 10.750 € (-1,38 %)     IMMOBEL 19.400 € (-2,51 %)     OXURION 0.003 € (0,00 %)     ECONOCOM GROUP 1.525 € (+3,74 %)     ATENOR 1.045 € (-1,88 %)     TITAN S.A. 50.150 € (-1,86 %)  
   VIRIDIEN 87.800 € (-2,88 %)     EXOSENS 54.750 € (-0,09 %)     METAVISIO 0.001 € (-13,33 %)     ATON 0.015 € (+5,71 %)     FDJ UNITED 22.030 € (-0,86 %)     AYVENS 10.620 € (-1,76 %)     PLANISWARE 24.000 € (+2,56 %)     HAVAS 18.050 € (+1,98 %)     LOUIS HACHETTE 1.736 € (-0,40 %)     BENFICA 6.680 € (+0,60 %)     MOTA ENGIL 4.792 € (-3,62 %)     STMICROELECTRONICS 41.695 € (-6,67 %)     AXA 43.730 € (+1,25 %)     POSTNL 0.865 € (-0,23 %)     SAINT GOBAIN 69.940 € (-2,21 %)     SOCIETE GENERALE 73.430 € (-1,73 %)     IMCD 97.320 € (+0,06 %)     RANDSTAD NV 38.360 € (+2,18 %)     EUROFINS SCIENT. 72.380 € (+2,38 %)     SAFRAN 321.700 € (-2,57 %)     SODEXO 56.450 € (+0,09 %)     MEDINCELL 22.000 € (+1,10 %)     EURONEXT 160.400 € (+1,39 %)     PROSUS 35.845 € (+0,65 %)     HERMES INTL 1 417.500 € (+1,29 %)     ING GROEP N.V. 31.875 € (-0,67 %)     LVMH 416.800 € (+0,36 %)     CREDIT AGRICOLE 18.470 € (-0,83 %)     CARREFOUR 16.545 € (+1,69 %)     WAVESTONE 30.475 € (+1,08 %)     BNP PARIBAS ACT.A 102.740 € (-0,98 %)     SCHNEIDER ELECTRIC 271.300 € (-6,80 %)     EMEIS 12.410 € (-0,88 %)     SBM OFFSHORE 35.100 € (-1,79 %)     CSG 15.878 € (+1,50 %)     SEMCO TECHNOLOGIES 39.250 € (-3,92 %)     EIFFAGE 106.550 € (-0,79 %)     SOITEC 123.050 € (-12,82 %)     RENAULT 29.360 € (-0,74 %)     VALLOUREC 18.145 € (-2,10 %)     TF1 6.770 € (+0,07 %)     VEOLIA ENVIRON. 31.350 € (-0,29 %)     AEGON 7.844 € (-0,68 %)     TOTALENERGIES 79.500 € (+0,93 %)     GROUPE SFPI 1.860 € (-0,53 %)     CELLECTIS 1.517 € (-42,41 %)     OVH 15.400 € (+3,29 %)     LINEDATA SERVICES 47.600 € (+0,21 %)     ESSILORLUXOTTICA 148.300 € (+1,30 %)     AMG 29.140 € (-3,12 %)     MAUREL ET PROM 8.420 € (+3,44 %)     ACCOR 45.670 € (-0,87 %)     BILENDI 10.000 € (-6,19 %)     EXOR NV 71.150 € (-0,14 %)     2CRSI 27.100 € (-5,97 %)     THERMADOR GROUPE 70.000 € (-1,82 %)     ALPES (COMPAGNIE) 18.700 € (-0,21 %)     NX FILTRATION 3.105 € (0,00 %)     COVIVIO 47.880 € (+0,42 %)     BOIRON 25.400 € (-2,31 %)  
News Réglementées
03/01/2023 09:30

Empower Clinics Subsidiary Signs Laboratory Services Agreement with US Healthcare Provider for Underserved Americans

MediSure Laboratory will provide clinical laboratory services to Specialist Network of North America as part of recently announced partnership

VANCOUVER, BC / ACCESSWIRE / January 3, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - today announced that Medisure Laboratory ("Medisure labs") signed a clinical laboratory services agreement with Specialist Network of North America Inc. (SSNA).

The agreement follows the partnership announced on December 7th between Empower and SNNA to launch a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US.

The Laboratory Services Agreement will provide SNNA the opportunity to offer its patients a full range of required cardiology screening panels and point-of-care testing products that are integral to diagnosis and the provision of treatment options. Medisure Labs generates new consistent monthly revenue and plays an important role in helping underserved patients.

"This agreement is exactly the type of accretive benefit that I envisioned when Empower partnered with SSNA last month", stated Steven McAuley, Chairman and CEO of Empower Clinics "With Medisure Labs, we have a laboratory that has state-of-the art technology and a pristine operating environment. We continue to aggressively pursue and replicate laboratory service agreements like the one with SSNA to maximize our return on investment in Medisure Laboratory."

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT SPECIALIST NETWORK OF NORTH AMERICA

https://specnethealth.com/

We are a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US. We aim to facilitate the effective and timely delivery of that care by creating and deploying a collaborative network of strategic partnerships including clinics, telemedicine and insurance providers.

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Media:

Steven McAuley
CEO
s.mcauley@empowerclinics.com
+1 855-855-9058

Investors:

Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the likelihood or ability for the Company to secure new testing business from SNNA. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Empower Clinics Inc.



View source version on accesswire.com:
https://www.accesswire.com/733754/Empower-Clinics-Subsidiary-Signs-Laboratory-Services-Agreement-with-US-Healthcare-Provider-for-Underserved-Americans

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière